As “The ribosome company” we develop sophisticated tools to capture ribosomes in an active state and characterize their components. Our unique technologies are first-in-class systems allowing for simultaneous measurement of newly synthesized proteins and the RNA template from which they are produced for delivering the highest level of correlation between gene expression and the proteome. The present platform includes IP covering our technologies and is dedicated to research-use-only (RUO) products with the potential to accelerate the path toward the discovery of novel therapeutic strategies in cancer, other human diseases, and congenital disorders. IMMAGINA is expected to fully underpin the immense diagnostic potential of our growing product portfolio to guide better decisions in precision medicine, working together with our partners towards better health for all.